Shows
EU News DailyWauquiez Proposes Detaining Foreigners, French Assembly Debates Voting Reform, US Tariffs Threaten European Pharma, Germany Faces Nursing Crisis, and more...(0:10): Wauquiez's Proposal to Detain Foreigners in Saint-Pierre-et-Miquelon Sparks Political Outrage(2:37): French Assembly Debates Controversial Reform to Paris, Lyon, Marseille Voting System(5:26): U.S. Tariffs Threaten European Pharma Industry's Future; EFPIA Calls for Urgent EU Reforms(7:48): Germany's Nursing Sector Faces Crisis as Over 1,200 Care Facilities Close Amid Financial Struggles(10:22): Germany Probes Possible Russian Link in Mannheim Attack Amid Election Security ConcernsTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Ouest-France2025-04-0913 min
The bluEPrint by Executive PlatformsMartin Müller & Søren Thuesen Pedersen of Novo Nordisk — Collaboration Among Industry Peers to Move the Life Sciences ForwardAt the 2024 edition of the Biomanufacturing World Summit series we sat down with Martin Müller and Søren Thuesen Pedersen of Novo Nordisk to talk about opportunities biopharmaceutical manufacturers have to work together to lower costs, standardize equipment, build win-win scenarios for procurement and supply chain, and similar initiatives where competitive advantage and IP are not at stake, but costs and compliance and other performance metrics can be improved through joining forces and agreeing on things collectively rather than each company having to reinvent its own wheel on every issue. Building upon their earlier presentation that covered much of...2024-12-1624 min
BBMRI-ERIC Podcast25 - ELSI Dialogues: Communicating with patient citizens on implementing the European Health Data Space (EHDS)“Without the patient citizen’s data, there is no future for research.”Episode 25 takes you to a workshop on information points for citizens under the European Health Data space. The workshop is jointly organised under the EHDS2Pilot project by BBMRI-ERIC’s ethical, legal and societal implications team and the Spanish Research Council in Brussels – CSIC where the workshop is being held.The project brings together 17 partners including health data access bodies, health data sharing infrastructures and European agencies with the aim to build a pilot version of the European Health Data Space (EHDS...2024-11-0638 min
EMJ GOLD: Pharma marketing, medical & moreS07 E06: AZ’s Stefan Woxström on why without health, we don’t have anythingTune in to the latest episode of the EMJ GOLD podcast as Isabel and Jade cross the halfway point of the season with special guest host Dr Jonathan Sackier of the EMJ podcast. In this episode, the team listen back to Jonathan's discussion with Stefan Woxström, Senior Vice President Europe and Canada, AstraZeneca at Reuters Events: Pharma 2024 in Barcelona. Together, the two unpick the current small molecule funding landscape, how to improve incentives to invest in rare diseases, how to better inform policymakers about the difference they can make and much more. A little m...2024-07-1640 min
Vital Health PodcastChristian Schneider, CMO Biopharma ExcellenceChristian Schneider is the Chief Medical Officer of Biopharma Excellence, and was formerly the Chief Scientific Officer at the UK’s MHRA. He was the Medical Head for Licensing at the Danish Medicines Agency, and a member of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency. In this podcast, we discuss the continuing challenges to Europe’s Biopharma competitiveness, and how an improved regulatory environment could be a benefit. Christian also highlights both the risks and opportunities of the EU’s proposed revision of the general pharmaceutical legislation. This podcas...2023-11-0849 min
Loose Women in PharmaEpisode 7: Compliance joy with Rina NewtonIf you have ever felt like the ABPI/EFPIA Codes of Practice are all about scary ‘NOs’, this will come as a breath of fresh air!
Rina Newton, Code expert and Co-Founder of 'Code Clarity' explains what posts you CAN like and share on social media. Rina is absolutely passionate about compliance and makes it accessible and enjoyable. Yes, you really did read that! Enjoyable!
Rina and Code Clarity’ Co Founder Jean Woolcock, believe that compliance confidence should belong to the many, and not just the few. Hurrah for that!htt...2023-07-1329 min
Vital Health PodcastNikolai Brun - Improving Europe's Biopharma LegislationNikolai Brun is a rare regulator who has rolled up his sleeves and successfully helped bring a therapy to market. He was part of a team at Genmab that discovered one of the first monoclonal antibodies for treating cancer. Nikolai was previously the Chief Medical Officer (CMO) of the Danish Medicines Agency, and has recently gone back into industry, as the CMO of the Swedish biotech company, Affibody. In this Vital Health Podcast, Nikolai Brun outlines why Europe’s biopharmaceutical sector is falling behind the rest of the world's and how the proposed EU pharmaceutical legislation, while con...2023-05-311h 01
Signalise: a Dazzle4Rare PodcastEP22: Signalising Newborn Screening with Screen4Care EFPIA Lead, Dr. Nicolas GarnierWelcome to this episode of Signalise: a Dazzle4Rare podcast. In this episode, we’re joined by Dr. Nicolas Garnier (French pronunciation: [ni.ko.la]) who’ll tell us a bit about himself and his work.
We’d planned to discuss Dr. Garnier’s work in new-born screening and the topic broadly but I couldn’t help myself; I wanted to get a more full understanding on his current project, Screen4Care where he is the consortium lead.
I think of Dazzle4Rare as a community service to our rare and associated communities so I’m glad that...2023-05-2437 min
apolut: TagesdosisEMA-Präsidentin mit Fehlinformationen vor EU-Sonderausschuss | Von Bastian BaruckerEin Kommentar von Bastian Barucker.Emer Cooke fungiert seit September 2020 als Direktorin der europäischen Arzneimittelagentur EMA. Vor ihrer Ernennung arbeitete die Pharmazeutin und Betriebswirtin bei der Weltgesundheitsorganisation sowie als Managerin für wissenschaftliche und regulatorische Angelegenheiten bei der EFPIA , dem europäischen Verband der pharmazeutischen Industrie in Brüssel. Am 27. März 2023 erschien Emer Cooke vor dem Sonderausschuss zur COVID-19-Pandemie des europäischen Parlaments, um Fragen der Abgeordneten bezüglich der Covid-19-Impfungen zu beantworten. Der Ausschuss hatte zuvor bereits hohe Pfizer- und Moderna-Angestellte befragt und dabei unter anderem herausgefunden, dass der Covid-19-Impfstoff von Pfizer bei...2023-04-1508 min
Health ConversationHow can we navigate COVID-19 in a new winter health landscape?Welcome to Health Conversation. Today we're asking Jo Atkinson, Anti-Infectives Product Lead at Pfizer, 'How can we navigate COVID-19 in a new winter health landscape?'. Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2023-02-0213 minHealth ConversationWhat is the waiver impact on innovation and pandemic preparedness?Welcome to Health Conversation. Today we're asking Claire Skentelbery, Director General of EuropaBio, 'What is the waiver impact on innovation and pandemic preparedness?'. Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2022-12-1213 minHealth ConversationWhy is a therapeutics waiver extension different to the vaccine waiver?Welcome to Health Conversation. Today we're asking Koen Berden, Executive Director for International Affairs at EFPIA, 'Why is a therapeutics waiver extension different to the vaccine waiver?'. Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2022-12-0516 minHealth ConversationWhat would a TRIPS waiver extension mean for diagnostics?Welcome to Health Conversation. Today we're asking Jesús Rueda Rodríguez, Strategies, Special Projects & International Affairs Director General at MedTech Europe, 'What would a TRIPS waiver extension mean for diagnostics?'. Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2022-11-2814 minHealth ConversationWhat would be the impact of a TRIPS waiver extension?Welcome to Health Conversation. Today we're asking Peter Guenter, CEO of Healthcare at Merck, 'What would be the impact of a TRIPS waiver extension?'. Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2022-11-2116 min
ZdraveZpravy.cz - Zprávy ze zdravotnictvíEHDS nemá smysl uspěchat, říká Thomas Brookland z EFPIAEuropean Health Data Space bylo hlavní téma konference [15.11.] Hospodářské komory ČR a Asociace inovativního farmaceutického průmyslu. Byl na ní Thomas Brookland z European Federation of Pharmaceutical Industries and Associations.
Sdílení zdravotnických dat napříč zeměmi EU bylo i téma podcastu ZdraveZpravy.cz s Thomasem Brooklandem. Předně je třeba říci, že Thomas Brookland je ve věci přípravy a zavádění European Health Data Space [EHDS] optimista. Už kvůli tomu, že EHDS je, jak říká, velice obsáhlý a ambiciózní projekt. Proto ho nelze do praxe zavést ze dne na den.
„Důleži...2022-11-1517 min
Voice of EHDENA perspective on health data, public private partnership and the pharmaceutical industry, with Magda Chlebus, European Federation of Pharmaceutical Industries & Associations (EFPIA)In this fourth episode we have a conversation with Magda Chlebus, Executive Director, Science, Policy & Regulatory Affairs at EFPIA, exploring both her career and work in relation to health data, public private partnerships (IMI, IHI) and the importance of both to the Pharmaceutical Industry.
EFPIA is the representative federation of R&D-based pharmaceutical companies, creating a collaborative environment for its members to innovate, discover, develop and deliver new therapies and vaccines for the people of Europe. More recently, via IMI2, Partners in Research was created to also include non-pharmaceutical partners of EFPIA, recognising the diverse nature of...2022-10-2838 min
Global Economy PodcastEpisode 79: IP in the EU FTA’s Series: The Importance of Strong IP Provisions in EU Trade Agreements with Koen BerdenIn this online conversation, Jacki Davis talks to Koen Berden, Executive Director for International Affairs at EFPIA – the European Federation of Pharmaceutical Industries and Associations, which supported the work on a recent ECIPE study entitled “The Benefits of Intellectual Property Rights in EU Free Trade Agreements”.
They discuss global competitiveness, strategic resilience and the central issue addressed by this study – the importance of strong IP provisions in EU trade agreements. 2022-05-0317 min
Global Economy PodcastEpisode 78: IP in the EU FTA’s Series: Relevance of IP for the Innovative Pharmaceutical Industry with Nathalie MollIn this online conversation, Jacki Davis talks to Nathalie Moll, Director-General of EFPIA – the European Federation of Pharmaceutical Industries and Associations, which supported the work on a recent ECIPE study entitled “The Benefits of Intellectual Property Rights in EU Free Trade Agreements”.
They discuss the importance of strong IP provisions in EU trade agreements, the European Commission's revision of a Pharmaceutical Strategy, and the proposal of Industrial Strategy. Ms Moll explains how important these strategies are for the industry and the principal risks and opportunities related to the pharmaceutical strategy. 2022-04-1918 minHealth ConversationHow can we support medical innovation in Europe?Welcome to Health Conversation. Today we're asking Nathalie Moll, Director General at EFPIA, 'How can we support medical innovation in Europe?'. Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2022-04-1921 min
Progress, Potential, and Possibilities Podcast / ShowDr. Erin Duffy, Ph.D. & Kevin Outterson, ESQ - Combating Antibiotic-Resistant Bacteria (CARB-X)Send us a textThe Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X - https://carb-x.org/) is a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria, a leading cause of death around the world. 1.27 million deaths worldwide were attributed to resistant bacterial infections in 2019. The CARB-X portfolio is the world’s most scientifically diverse, early development pipeline of new antibiotics, vaccines, rapid diagnostics and other products and represents the only global partnership that integrates solutions for the prevention, diagnosis and treatment of life-threatening bacterial infections, translating innovation from basic research to first-in-human clinical trials. Dr. Erin Du...2022-04-191h 02
Data BytesAdvancements in AI in the Pharmaceutical Industry with Christine Fletcher - Industry Case Study In this episode, Chrissie discuss the data sources used for pharmaceutical research and developments, the ethical issues arising with the use of data in the pharmaceutical industry, and what the future of AI looks like in the pharmaceutical industry.
About Christine Fletcher
Chrissie is the Vice President of Development Statistics at GlaxoSmithKline. She leads a group of statisticians supporting the development of new and approved medicines in immunology, hepatology/gastrointestinal, respiratory, cardiovascular, neuroscience, HIV, global health and infectious disease areas. Chrissie has worked in the Pharmaceutical Industry for 30 years and has experience of developing and com...2022-01-1324 min
Health ConversationHow can the EU be better prepared for cross-border health threats?Welcome to 19 Conversations. Today we're asking Sara Cerdas, MEP and Mariano Votta, Director, Active Citizenship Network "How can the EU be better prepared for cross-border health threats?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-12-1433 minHealth ConversationWhat is needed from the EMA to be better prepared for future health threats?Welcome to 19 Conversations. Today we're asking Michel Stoffel, Senior Adviser Global Regulatory Affairs, GSK and Isabelle Bekeredjian-Ding, Head of Microbiology Division, Paul-Ehrlich-Institut "What is needed from the EMA to be better prepared for future health threats?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-12-0721 min
Dr. GPCR Podcast#53 with Dr. Timo De GroofAbout Dr. Timo De Groof
Dr. Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in 2015. During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry. During his last year of studies, Timo performed research in the biopharmaceutical company Argen x and gained experience in the identification and characterization of llama-derived antibodies in inflammatory diseases and oncology.
From 2015 to 2019, he completed his Ph.D. in the Medicinal Chemistry group at VU University Amsterdam under the supervision of prof. dr. Martine Smit. During his Ph.D., Timo, t...2021-10-2856 min
THE EPSA PODCASTEPSA Podcast S2 E1 / Flu Vaccination - Pharmacists in vaccinationIn the first episode of the EPSA Podcast Season 2 we talk about Flu Vaccination and the impact Pharmacists make in vaccination, as well as whether or not the University Curricula includes all the information we need about vaccines.Meet our guests!Sibilia Quilici - Executive Director Vaccines Europe, EFPIAJan De Belie - Professional Affairs Advisor PGEUMarianna Gajda & Joanna Oberska - Organisers of "Vaccines, it doesn't hurt!", PPSA PolandHere are only a few of the questions you'll receive answers to in...2021-10-2032 min
Health ConversationWhat is needed from the ECDC to be better prepared for future health threats?Welcome to 19 Conversations. Today we're asking Prof. Paolo Bonanni, MD, Professor of Hygiene & Public Health, University of Florence, Prof. Dr Joe Schmitt, Editor in Chief, Global Health Press and Sibilia Quilici, Executive Director, Vaccines Europe "What is needed from the ECDC to be better prepared for future health threats?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-10-0430 min
RPS Pharma SceneRPS Pharma Scene #03This episode, RPS Chief Scientist Gino Martini chats with Nathalie Moll and Sunayana Shah about the role of industrial pharmacy, and their experiences as pharmacists during the pandemic. Nathalie has been Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA) since 2017. And Sunayana is an expert in regulatory, medical, and pharmacovigilance policy development. Join them to discover how industrial pharmacy is changing and contributing to healthcare around the world. Hosted on Acast. See acast.com/privacy for more information.2021-10-0124 min
Health ConversationHow is precision medicine transforming cancer care?Welcome to 19 Conversations. Today we're asking Dr Dominik Mumberg, Translational Innovation Lead, Bayer and Dr Mathias Rossberg, VP, Business Unit Head, Oncology & Haematology, Bayer "How is precision medicine transforming cancer care?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-09-2020 min
IDEA ColliderIDEA Collider | Susanne Schaffert, PhDAs President of Novartis Oncology, Susanne Schaffert is pursuing a bold strategy to reimagine the research, development and commercialization of innovative treatments that will help improve and extend the lives of people with cancer and related blood disorders. Susanne has held positions of increasing seniority across a range of business areas during her career at Novartis, having first joined the company as a sales representative in Germany in 1995. The majority of her roles have been in oncology, where she has a passion for making a difference in the lives of patients. Prior to her current po...2021-07-3051 min
The Parkinson's Life PodcastLiving with 'advanced' Parkinson's diseaseIn this episode, which has been initiated and funded by Britannia Pharmaceuticals, we’re looking at what it means to reach an advanced stage of the condition.Because Parkinson’s disease is so individualised, its progression is not black and white. The term ‘advanced’ Parkinson’s generally refers to the stage at which symptoms have a bigger impact on day-to-day life. At this stage, medications may not be as effective and people with the condition may begin to rely more on care.Our first guest is Colin Cheesman, a former local authority chief executive based in Chester...2021-06-1739 min
Health ConversationFrom raw materials to patients’ arms – how are COVID-19 vaccines made?Welcome to 19 Conversations. Today we're asking Luc Van Steenwinkel, Site Lead, Pfizer Puurs and Vice President Pfizer Biotech Operations, and Danny Hendrikse, Vice President, Pfizer Global Supply Chain, "From raw materials to patients’ arms – how are COVID-19 vaccines made?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-06-1014 min
Health ConversationHow is the pharmaceutical industry contributing to a healthy environment?Welcome to 19 Conversations. Today we're asking Lars Fruergaard Jorgensen, President & Chief Executive Officer, Novo Nordisk "How is the pharmaceutical industry contributing to a healthy environment?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-05-3109 min
Health ConversationHow can we improve healthcare access for marginalised communities?Welcome to 19 Conversations. Today we're asking Alyna Smith, Senior Advocacy Officer, Platform for International Cooperation on Undocumented Migrants and Boris Azaïs, Director Public Policy Europe Canada, MSD "How can we improve healthcare access for marginalised communities?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-05-0517 min
Health ConversationWhat value do Public Private Partnerships bring for society?Welcome to 19 Conversations. Today we're asking Professor Michel Goldman, previous IMI Executive Director and Dr Pierre Meulien, current IMI Executive Director "What value do Public Private Partnerships bring for society?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-04-2919 min
Health ConversationHow can vaccines help in Europe's fight against cancer?Welcome to 19 Conversations. Today we're asking Nicoletta Luppi, Senior Vice President and Managing Director, MSD Italy "How can vaccines help in Europe's fight against cancer?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-04-2715 min
Health ConversationShould Europe relocate pharmaceutical production to within the EU?Welcome to 19 Conversations. Today we're asking Dr Koen Berden, Executive Director for International Trade, EFPIA "Should Europe relocate pharmaceutical production to within the EU?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-03-2426 min
Health ConversationHow can monoclonal antibodies help in the fight against COVID-19?Welcome to 19 Conversations. Today we're asking Dr Janelle Sabo, Global Therapeutics Platform Leader, Eli Lilly and Company "How can monoclonal antibodies help in the fight against COVID-19?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-03-2411 min
Health ConversationIs intellectual property a barrier to access?Welcome to 19 Conversations. Today we're asking Prof. Dr. Walter Van Dyck, Director of Healthcare Management Centre, Vlerick Business School "Is intellectual property a barrier to access?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-03-1524 min
Health ConversationHow can we future-proof medicines regulation in the post-COVID world?Welcome to 19 Conversations. Today we're asking Nathalie Moll, Director General of EFPIA, "How can we future-proof medicines regulation in the post-COVID world?". Listen to hear the discussion on this challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-03-0915 min
Health ConversationFighting the fakes - what's industry's role?Welcome to 19 Conversations. Today we're asking Catherine Boudot, Director of the Trademark Department, Servier "Fighting the fakes - what's industry's role?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-02-1816 min
Health ConversationCan a shared understanding of unmet medical needs support innovation?Welcome to 19 Conversations. Today we're asking Chris Skedgel, Director of Health Economics "Can a shared understanding of unmet medical needs support innovation?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-02-1015 min
Vital Health PodcastPharmaCCX, a tech savvy solution for pricing EU cancer drugsThe cost of new, highly targeted cancer therapies is becoming a serious political issue in the US, as it has been in Europe for many years. Europeans feel that drug prices are too high, which explains why trying to use a combination of such drugs, which is increasingly recommended as the best approach from a clinical standpoint, is often both politically and economically untenable.That’s the problem my two guests today are trying to solve. Nathan Sigworth and Richard Bergström founded the innovative startup PharmaCCX, an independent, third-party technology platform focused on improving patient outcomes by hel...2021-01-2853 min
Health ConversationHas COVID-19 transformed telemedicine forever?Welcome to 19 Conversations. Today we're asking Paul Robinson, European Patient Engagement Lead, MSD and Weronika Burkot, Patient Representative, International Diabetes Federation "Has COVID-19 transformed telemedicine forever?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-01-1819 min
Health ConversationHow is the pharmaceutical industry contributing to the fight against COVID-19?Welcome to 19 Conversations. Today we're asking Johanna Mercier, Chief Commercial Officer, Gilead "How is the pharmaceutical industry contributing to the fight against COVID-19?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2021-01-1116 min
Health ConversationHave you dropped the ball on antimicrobial resistance (AMR)?Welcome to 19 Conversations. Today we're asking Thomas Cueni, Director General, International Federation of Pharmaceutical Manufacturers (IFPMA) "Have you dropped the ball on antimicrobial resistance?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2020-12-1523 min
Health ConversationCan we expect a cure for Alzheimer's soon?Welcome to 19 Conversations. Today we're asking David Jefferys, Senior Vice President for Global Regulatory, Healthcare Policy and Corporate Affairs, Eisai Europe and Chair of EFPIA's Alzheimer's disease platform and Philip Scheltens, Professor of Neurology and Director of the Alzheimer Centre in Amsterdam "Can we expect a cure for Alzheimer's soon?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2020-12-0918 min
Health ConversationIs the pharmaceutical industry making too much money?Welcome to 19 Conversations. Today we're asking Jack Scannell, Independent Consultant and Honorary Fellow at the School of Social and Political Science, The University of Edinburgh "Is the pharmaceutical industry making too much money?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2020-12-0217 min
Health ConversationCan we develop better medicines for children faster?Welcome to 19 Conversations. Today we're asking Angelika Joos, Executive Director, Global Regulatory Policy, MSD "Can we develop better medicines for children faster?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2020-11-1915 min
Health ConversationIs industry doing enough to tackle antimicrobial resistance?Welcome to 19 Conversations. Today we're asking Elizabeth Hermsen, Head of Global Antimicrobial Stewardship, MSD and Bruce Altevogt, Vice President and Head of External Medical Engagement, Hospital Business Unit, Pfizer "Is industry doing enough to tackle antimicrobial resistance?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2020-11-1718 min
Health ConversationHow can Europe be better prepared for future pandemics?Welcome to 19 Conversations. Today we're asking Olivier Charmeil, Executive Vice President, General Medicines, Sanofi "How can Europe be better prepared for future pandemics?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2020-11-1717 min
Health ConversationCan the pharmaceutical industry be more transparent?Welcome to 19 Conversations. Today we're asking Andy Powrie-Smith, Executive Director of Communications & Partnerships, EFPIA "Can the pharmaceutical industry be more transparent?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2020-11-1216 min
Health ConversationHow can we keep SMEs in Europe?Welcome to 19 Conversations. Today we’re asking Erik van den Berg, Chief Executive Officer, AM Pharma "How can we keep SMEs in Europe?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2020-11-0419 min
Health ConversationWill the pharmaceutical strategy achieve its aims?Welcome to 19 Conversations. Today we're asking Nathalie Moll, Director General, EFPIA "Will the pharmaceutical strategy achieve its aims?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2020-10-2216 min
Health ConversationHow does a pharmaceutical SME function?Welcome to 19 Conversations. Today we're asking Dr. Holger Zimmermann, Chief Executive Officer, AiCuris "How does a pharmaceutical SME function?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2020-10-1520 min
5 Questions With...5 Questions With Dr Dean Jenkins FRCPCeleste Kolanko, Managing Director at Liberum IME, will be joined by Dean Jenkins who offers a broad insight into the future of healthcare education based on his knowledge and first-hand experience as a Consultant Physician, Owner, and Co-founder of technology-based companies, and his current role as Partner of External Medical Learning.
He currently supports medical learning and external engagement strategy and tactics as part of the HCP Engagement and Learning team within Global Medical Affairs at UCB.
He also represents medical learning with The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the...2020-10-1200 min
Health ConversationWho decides the price of a medicine?Welcome to 19 Conversations. Today we’re asking Richard Torbett, Chief Executive, Association of the British Pharmaceutical Industry "Who decides the price of a medicine?". Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.2020-10-0821 minHealth ConversationWill COVID-19 vaccines be safe?Welcome to 19 Conversations. In our first conversation, Jacki Davis asks Mariano Votta, Director of Active Citizenship Network, and Michel Stoffel, Vice-President, Head of Europe Region, Global Regulatory Affairs, GSK Vaccines if vaccines for COVID-19 will be safe. Listen to hear their discussion on the challenge and how we're preparing for the future.Presented by the European Federation of Pharmaceutical Industries and Association Hosted on Acast. See acast.com/privacy for more information.2020-09-1724 min
Health Conversation19 Conversations - TrailerHave questions about the healthcare industry? Welcome to 19 Conversations, where we will discuss today’s challenges and how we’re preparing for the future. Presented by the European Federation of Pharmaceutical Industries and Association Hosted on Acast. See acast.com/privacy for more information.2020-09-1600 min5 Questions With...5 Questions With Thomas Kellner & Suzanne Murray, Co-Chairs of the Global Alliance for Medical Education (GAME) Futurist ForumCeleste Kolanko, Managing Director at Liberum IME, will be joined by two guests.
Suzanne Murray, the CEO and Founder of AXDEV Group International since 1997. Her career and academic accomplishments, from McGill University and Concordia University, span over 25 years in organizational development, management, healthcare, education sciences, performance, and implementation research, in business and healthcare, and this on a global scale. She is a board Member of JECME, and Co-Chair of the GAME #FuturistForum.
Thomas Kellner, an experienced, independent consultant in Medical Education helping organizations and teams to evolve to a learning culture with a focus...2020-08-1030 min
P4A Let's Talk Rare: The Life Science PodcastWeekly Roundup: April 27, 2019This week, we look at the European Federation of Pharmaceutical Industries and Associations or EFPIA’s patient wait survey and its key findings as well as news developments in the spinal muscular atrophy world relating to gene therapy Novartis’ Zolgensma and Biogen’s Spinraza.
Presenter: Aparna Krishnan
Contributors: Sophie Schmitz, Jack Rawson
Producer: Aparna Krishnan
2019-04-2719 min
POLITICO's EU ConfidentialEpisode 72, presented by EFPIA: Bill Browder & Russia — US midterms — Picking politiciansOur main guest is Bill Browder, once the largest foreign investor in Russia but now a fierce critic of Vladimir Putin. He’s the driving force behind the Magnitsky Act — legislation designed to impose severe financial and travel sanctions on human rights abusers. Browder tells our chief Brussels correspondent, David Herszenhorn, the story behind the act and how he’s trying to bring it into the EU.
Also this week, the European People’s Party chose Manfred Weber as its lead candidate for the European Parliament election. But how much of a contest was it? Weber looked to have it wrapped...2018-11-0832 min
EU ConfidentialEpisode 72, presented by EFPIA: Bill Browder & Russia — US midterms — Picking politiciansOur main guest is Bill Browder, once the largest foreign investor in Russia but now a fierce critic of Vladimir Putin. He’s the driving force behind the Magnitsky Act — legislation designed to impose severe financial and travel sanctions on human rights abusers. Browder tells our chief Brussels correspondent, David Herszenhorn, the story behind the act and how he’s trying to bring it into the EU.Also this week, the European People’s Party chose Manfred Weber as its lead candidate for the European Parliament election. But how much of a contest was it? Weber looked to have...2018-11-0834 min
MWC Shanghai 2018Digitalising Healthcare in EuropeThe recent Mobile Meetings Series event “Digital Health – lots of potential, limited progress” gathered key EU stakeholders to explore the potential of digitising healthcare and the current barriers to introducing mobile technologies in the healthcare sector in Europe.
For this video, we invited MEP José Inácio Faria, Tapani Piha (European Commission), Brendan Barnes (EFPIA) and GSMA’s Joop Hazenberg to share their thoughts on the future of healthcare in Europe, the role of mobile and how the GSMA is helping to advance the deployment of digital health solutions in Europe and around the world.
Learn more about this event: https://ww...2018-04-1803 min
Friends of Europe podcastsAccess, care and diagnosis for rare diseasesFriends of Europe's debate focused on solutions to diagnose and cure rare diseases in Europe. Speakers included Yann Le Cam (Eurordis), Nathalie Moll (EFPIA), Xavier Prats Monné (European Commission), Maurizio Scarpa (MetabERN) and Kim Stratton (Shire).2017-06-221h 02
Tech Talks CentralTTC #220 Pharmaceuticals Need Data for New Drug DevelopmentRichard Bergström, Director General, of EFPIA explains why pharmaceuticals need data to analyse people’s habits and drug intake, in order to innovate and develop newer and better drugs. He talks about the effect of the economic crisis on pharmaceuticals and analyses how the global pharma canvas is set. Of course we didn’t lose the chance to ask his opinion on Shkreli / Daraprim and the Golden Ticket concept (priority review voucher), the FDA offers to stimulate rare disease drug research and whether it could be implemented in Europe. Interviewed by Vicki Kolovou for Tech Talks Central.2015-12-0900 min